Bladder Cancer Video Channel
Explore the latest insights and summaries from experts in Bladder Cancer.
Treatment Landscape
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New Treatments
FEATURING
Guru Sonpavde
- 2,023 views
- April 16, 2024
- 11
ecancer
Bladder Cancer Highlights From EAU 2024 Including CheckMate 274 and IMvigor011 Trials
- 234 views
- April 24, 2024
University of Colorado Cancer Center
NCCN Guidelines Updates for the Treatment of Metastatic Urothelial Cancer
FEATURING
Thomas Flaig
- 341 views
- May 6, 2024
- 1
University of Illinois Cancer Center
Recent Advances in Molecular-Guided Treatment of GU Malignancies
FEATURING
Natalie Reizine
- 235 views
- May 10, 2024
- 2
Weill Cornell Medicine Oncology & Hematology
Urothelial Carcinoma: New Developments
FEATURING
Cora Sternberg
- 347 views
- May 23, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
Bladder Cancer Highlights From ASCO® 2024
FEATURING
Guru Sonpavde
- 1,565 views
- June 10, 2024
- 11
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"
FEATURING
Erika Hamilton
- 1,585 views
- June 18, 2024
- 7
Miami Cancer Institute Precision Oncology Symposium
The Evolution of Treatment in Advanced Urothelial Carcinoma
FEATURING
Petros Grivas
- 82 views
- June 26, 2024
Memorial Sloan Kettering Cancer Center
Multidisciplinary Approaches for Muscle Invasive Bladder Cancer
FEATURING
Bernard Bochner
- 203 views
- July 9, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Bladder and RCC Highlights"
FEATURING
Karine Tawagi,
Natalie Reizine
- 266 views
- July 16, 2024
- 4
Nebraska Oncology Society
ASCO® 2024 Review: Treatment Options for Non-Metastatic MIBC
FEATURING
Nataliya Mar
- 144 views
- July 30, 2024
Nebraska Oncology Society
ASCO® 2024 Review: Metastatic Bladder Cancer Treated with EV + Pembro & Impact of PRO From EV-302
FEATURING
Nataliya Mar
- 58 views
- July 30, 2024
Integrity CE
Updates in the Treatment and Management of Bladder Cancer
FEATURING
Matthew Galsky,
Brendan Guercio
- 299 views
- August 2, 2024
- 1
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Key RCC/Bladder/Testicular GU Updates From ASCO® 2024
FEATURING
Jonathan Trujillo
- 53 views
- September 4, 2024
- 1
The View on GU | with Lalani & Wallis
Review of Bladder Cancer Updates From ASCO® GU 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 24 views
- September 5, 2024
The View on GU | with Lalani & Wallis
Review of GU Cancer Takeaways From ASCO® GU 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 51 views
- September 5, 2024
The View on GU | with Lalani & Wallis
Review of Bladder Cancer Updates From ASCO® 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 40 views
- September 6, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Practice-Changing Trials for Patients With Localized MIBC - NIAGARA and AMBASSADOR
FEATURING
Petros Grivas
- 260 views
- September 20, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Bladder Cancer Highlights - JCOG1019, TOMBOLA, and SunRISe-4
FEATURING
Bogdana Schmidt
- 124 views
- September 23, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Key Trial Results in Advanced Bladder Cancer Treatment
FEATURING
Guru Sonpavde
- 158 views
- September 24, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mCRPC) and NIAGARA (MIBC)
FEATURING
Robert Dreicer
- 359 views
- September 24, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: The Latest Data on NMIBC and Localized MIBC
FEATURING
Félix Guerrero-Ramos
- 56 views
- September 25, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la/mUC), NIAGARA (MIBC), and Other Updates
FEATURING
Elizabeth R. Plimack
- 189 views
- September 27, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC), and CheckMate 9ER (aRCC)
FEATURING
Camillo Porta
- 186 views
- October 2, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Novel Agents and Promising Combinations in mRCC and mUC
FEATURING
Begoña Pérez-Valderrama
- 73 views
- October 8, 2024
Yale Cancer Center
Key GU Cancer Trials of 2024: Treatment Advances in Urothelial and Prostate Cancer
FEATURING
Joseph Kim
- 162 views
- October 21, 2024
ecancer
ESMO 2024 Summary: Highlights & Analysis of the Biggest Solid Cancer Updates
FEATURING
Bishal Gyawali
- 46 views
- October 21, 2024
International Urology Cancer Summit - IUCS
Optimizing Treatment Strategies for Metastatic Upper Tract Urothelial Carcinoma
FEATURING
Patrizia Giannatempo
- 44 views
- October 23, 2024
International Urology Cancer Summit - IUCS
Contemporary Options in Non-Metastatic Bladder Cancer
FEATURING
Param Mariappan
- 40 views
- October 23, 2024
International Urology Cancer Summit - IUCS
2024 Updates on Candidates for Bladder-Sparing Treatment
FEATURING
Ananya Choudhury
- 36 views
- October 23, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Developmental Therapeutics Highlights
FEATURING
Guru Sonpavde
- 277 views
- October 25, 2024
- 3
Kyle Richards
Perioperative Chemotherapy for MIBC - Neoadjuvant, Adjuvant, and What's HOT in Systemic Therapies
- 119 views
- October 25, 2024
The View on GU | with Lalani & Wallis
Review of Bladder Cancer Updates From ESMO 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 122 views
- October 30, 2024
- 3
COR2ED The Heart of Medical Education
ESMO 2024 Summary: Key Trial Updates on IO and Targeted Treatments in GU Cancers
FEATURING
Ray Manneh Kopp
- 85 views
- November 4, 2024
- 1
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
Neoadjuvant Systemic Therapy in MIBC
FEATURING
Petros Grivas
- 127 views
- July 24, 2024
Félix Guerrero-Ramos
Panel Discussion: Managing Intermediate Risk NMIBC and Innovations in Intravesical Therapies
FEATURING
Karim Chamie
- 26 views
- September 24, 2024
ecancer
ESMO 2024 Insights: JCOG1019 Study - Watchful Waiting vs. Intravesical BCG in HGT1 Bladder Cancer
FEATURING
Hiroshi Kitamura
- 48 views
- October 16, 2024
- 1
Total Health
Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024
FEATURING
Melissa Reimers
- 532 views
- March 5, 2024
- 1
Total Health
Emerging Trends in Localized Bladder Cancer in 2024
FEATURING
Nikhil Gopal
- 179 views
- March 5, 2024
Insights from 2024 ASCO® GU Annual Meeting
Recent GU Developments and Their Clinical Implications
FEATURING
Thomas Powles,
Brian Rini
- 1,521 views
- March 7, 2024
- 6
AdventHealth
FDA Approval of Gemcitabine-Cisplatin + Nivo as 1L Therapy for Advanced Urothelial Carcinoma
FEATURING
Guru Sonpavde
- 274 views
- March 11, 2024
- 1
Dana-Farber Cancer Institute
Bladder Cancer Highlights From ASCO® GU 2024
FEATURING
Charlene Mantia,
Joaquim Bellmunt
- 164 views
- March 13, 2024
- 2
Scripps Health
Sequencing 2L & Later Line Therapies in Metastatic Urothelial Carcinoma
FEATURING
Petros Grivas
- 159 views
- March 14, 2024
Scripps Health
Sequencing 1L Therapies in Metastatic Urothelial Carcinoma
FEATURING
Petros Grivas
- 319 views
- March 14, 2024
Kriti Mittal
Current Updates in Urothelial Cancer: Clinical Implications for Practicing Clinician
- 402 views
- March 18, 2024
- 3
Houston Methodist
Cell Death-Induced Non-Classical Mechanisms of Therapy Resistance in Bladder Cancer
FEATURING
Keith Chan
- 23 views
- September 10, 2024
Ignacio Moncada
SIU 2024 Insights: The Robotics Era, an Update - Radical Cystectomy
- 8 views
- November 6, 2024
Oncology 2024 Year in Review
Year in Review 2024 - Bladder Cancer
FEATURING
Guru Sonpavde
- 180 views
- December 2, 2024
- 2
Jason Hafron
Year in Review: Bladder Cancer - 2024 Insights and Exciting Prospects for 2025
- 104 views
- December 16, 2024